Companies
Siasun Robot & Automation
a leading Chinese collaborative-robotics manufacturer (Shenyang, listed SZSE:300024), confirmed through investor-relations filings, revenue disclosures and industry ranking coverage as a top domestic collaborative-robot producer; no biopharma-specific deployment case study was confirmed in this screen.
- Country
- China
- Ticker
- SZSE:300024
SZSE:300024
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Publicly listed on Shenzhen Stock Exchange (SZSE: 300024) | robottoday.com |
| Capacity | Operates the largest industrial robot base in China with 220,000+ square meters of global production site area and robust large-scale production capabilities | en.siasun.com · roboticsbusinessnews.com |
| Certification | Certified by CE, UL, GOST, ESA, and CR | en.siasun.com · roboticsbusinessnews.com |
| Production site | Industrial parks in Shenyang, Shanghai, Qingdao, Tianjin, and Wuxi | china.org.cn · en.siasun.com · robottoday.com |
| Headcount | Approximately 3,580 to 3,637 employees worldwide (as of 2026) | tradingview.com |
| Revenue | 4.12 billion CNY (2025) | disc.static.szse.cn · reuters.com |
Independent sources: china.org.cn · disc.static.szse.cn · en.siasun.com · reuters.com · roboticsbusinessnews.com · robottoday.com · tradingview.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cobots for bioproduction | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.